 Jane Gross
Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium Infections, Nontuberculous | 5 | 2023 | 337 | 2.870 |
Why?
| | Cystic Fibrosis | 8 | 2023 | 957 | 2.680 |
Why?
| | Mycobacterium abscessus | 2 | 2022 | 98 | 1.320 |
Why?
| | Cross Infection | 2 | 2021 | 202 | 1.260 |
Why?
| | Nontuberculous Mycobacteria | 4 | 2023 | 207 | 1.220 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2023 | 17 | 0.870 |
Why?
| | Pyrrolidines | 1 | 2023 | 56 | 0.860 |
Why?
| | Dust | 2 | 2023 | 84 | 0.830 |
Why?
| | Pulmonary Medicine | 1 | 2023 | 88 | 0.810 |
Why?
| | Respiratory Insufficiency | 2 | 2023 | 292 | 0.800 |
Why?
| | Quinolones | 1 | 2023 | 97 | 0.790 |
Why?
| | Neuromuscular Diseases | 1 | 2023 | 90 | 0.790 |
Why?
| | Mycobacterium | 1 | 2023 | 103 | 0.780 |
Why?
| | Indoles | 1 | 2023 | 309 | 0.740 |
Why?
| | Pyrazoles | 1 | 2023 | 362 | 0.700 |
Why?
| | Pyridines | 1 | 2023 | 425 | 0.680 |
Why?
| | Infection Control | 1 | 2019 | 136 | 0.620 |
Why?
| | Lung Diseases | 3 | 2019 | 710 | 0.610 |
Why?
| | Environmental Exposure | 2 | 2018 | 378 | 0.610 |
Why?
| | Silicon Dioxide | 1 | 2018 | 94 | 0.600 |
Why?
| | Pneumonia | 1 | 2023 | 576 | 0.590 |
Why?
| | Betacoronavirus | 3 | 2020 | 254 | 0.430 |
Why?
| | Pneumonia, Viral | 3 | 2020 | 344 | 0.370 |
Why?
| | Coronavirus Infections | 3 | 2020 | 336 | 0.370 |
Why?
| | Disease Transmission, Infectious | 2 | 2020 | 57 | 0.350 |
Why?
| | Vaping | 2 | 2019 | 46 | 0.320 |
Why?
| | Drug Combinations | 2 | 2023 | 289 | 0.250 |
Why?
| | Humans | 20 | 2023 | 115589 | 0.230 |
Why?
| | Pandemics | 3 | 2020 | 1334 | 0.230 |
Why?
| | Chloride Channel Agonists | 1 | 2023 | 62 | 0.210 |
Why?
| | Mycobacterium avium Complex | 1 | 2023 | 92 | 0.210 |
Why?
| | Respiration | 1 | 2023 | 177 | 0.210 |
Why?
| | Benzodioxoles | 1 | 2023 | 83 | 0.200 |
Why?
| | Aminophenols | 1 | 2023 | 112 | 0.200 |
Why?
| | Water | 1 | 2023 | 412 | 0.180 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 50 | 0.180 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2023 | 288 | 0.170 |
Why?
| | September 11 Terrorist Attacks | 1 | 2019 | 22 | 0.170 |
Why?
| | Aerosols | 1 | 2020 | 150 | 0.170 |
Why?
| | Adenoviridae Infections | 1 | 2019 | 15 | 0.160 |
Why?
| | Inhalation Exposure | 1 | 2019 | 102 | 0.160 |
Why?
| | Measles | 1 | 2019 | 38 | 0.160 |
Why?
| | Volcanic Eruptions | 1 | 2018 | 6 | 0.160 |
Why?
| | Adult | 4 | 2023 | 30719 | 0.150 |
Why?
| | Sleep | 1 | 2023 | 625 | 0.150 |
Why?
| | Risk Factors | 2 | 2021 | 8697 | 0.150 |
Why?
| | Safety Management | 1 | 2018 | 110 | 0.150 |
Why?
| | Curriculum | 1 | 2023 | 852 | 0.140 |
Why?
| | Occupational Exposure | 1 | 2019 | 262 | 0.140 |
Why?
| | Respiratory Tract Diseases | 1 | 2018 | 142 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 667 | 0.140 |
Why?
| | Delivery of Health Care | 1 | 2023 | 844 | 0.140 |
Why?
| | Disease Outbreaks | 1 | 2019 | 308 | 0.130 |
Why?
| | Air Pollutants | 1 | 2018 | 246 | 0.120 |
Why?
| | Antibodies, Monoclonal | 1 | 2021 | 1265 | 0.120 |
Why?
| | Ectodermal Dysplasia 1, Anhidrotic | 1 | 2014 | 1 | 0.120 |
Why?
| | Sweat | 1 | 2014 | 38 | 0.110 |
Why?
| | Patient Education as Topic | 1 | 2018 | 686 | 0.110 |
Why?
| | Chlorides | 1 | 2014 | 130 | 0.110 |
Why?
| | Mutation | 1 | 2023 | 3364 | 0.100 |
Why?
| | Risk Assessment | 2 | 2018 | 2987 | 0.100 |
Why?
| | Military Personnel | 1 | 2019 | 525 | 0.100 |
Why?
| | Colorado | 1 | 2022 | 4113 | 0.100 |
Why?
| | Prospective Studies | 1 | 2023 | 6264 | 0.100 |
Why?
| | Lung | 1 | 2023 | 3672 | 0.090 |
Why?
| | United States | 3 | 2019 | 12295 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 1829 | 0.070 |
Why?
| | Male | 4 | 2021 | 55949 | 0.070 |
Why?
| | Female | 4 | 2021 | 59913 | 0.070 |
Why?
| | Child | 1 | 2023 | 18489 | 0.060 |
Why?
| | Measles Vaccine | 1 | 2019 | 17 | 0.040 |
Why?
| | Iraq | 1 | 2019 | 81 | 0.040 |
Why?
| | Afghanistan | 1 | 2019 | 108 | 0.040 |
Why?
| | Hawaii | 1 | 2018 | 38 | 0.040 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2019 | 73 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 608 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2019 | 2392 | 0.030 |
Why?
| | False Negative Reactions | 1 | 2014 | 50 | 0.030 |
Why?
| | Gene Silencing | 1 | 2014 | 175 | 0.030 |
Why?
| | Cough | 1 | 2012 | 107 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2012 | 165 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2012 | 135 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1357 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4665 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1598 | 0.020 |
Why?
| | Young Adult | 1 | 2019 | 10470 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 9133 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 26998 | 0.010 |
Why?
| | Adolescent | 1 | 2012 | 17890 | 0.010 |
Why?
|
|
Gross's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|